Advertisement

Correction to: Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trial

  • Paolo Martelletti
  • Piero Barbanti
  • Licia Grazzi
  • Giulia Pierangeli
  • Innocenzo Rainero
  • Pierangelo Geppetti
  • Anna Ambrosini
  • Paola Sarchielli
  • Cristina Tassorelli
  • Eric Liebler
  • Marina de Tommaso
  • on Behalf of the PRESTO Study Group
Open Access
Correction
  • 186 Downloads

Correction

Following publication of the original article [1], the authors notified us that the citation within the Table 1 legend was not presented as initially requested. Also, the word “efficacy” was missed from the background section.

The original publication has been corrected. The incorrect and correct table citations as well as background information are presented below.
  • Originally published citation:

© 2018 Tassorelli C, Grazzi L, de Tommaso M, Pierangeli G, Martelletti P, Rainero I, Dorlas S, Geppetti P, Ambrosini A, Sarchielli P, Liebler E, Barbanti P, PRESTO Study Group (2018) Non-invasive vagus nerve stimulation as acute therapy for migraine: the randomized PRESTO study [published online June 15, 2018]. Neurology:doi: https://doi.org/10.1212/WNL.0000000000005857. www.neurology.org. Adapted with permission

Abbreviations: DB Double-blind, NA Not applicable, nVNS Non-invasive vagus nerve stimulation, SD Standard deviation

aNo. of days the patient typically takes acute migraine medication per month. bPatients with no reported baseline severity were excluded from this analysis
  • Corrected citation:

© 2018 Tassorelli C, Grazzi L, de Tommaso M, et al. Noninvasive vagus nerve stimulation as acute therapy for migraine: the randomized PRESTO study. Neurology. 2018;91(4):e364-e373. Adapted with permission
  • Original Background paragraph:

Opioids should be discouraged for the acute treatment of migraine due to significant safety concerns and lack of documented but remain frequently used in the emergency department setting, which significantly increases healthcare costs
  • Corrected Background paragraph:

Opioids should be discouraged for the acute treatment of migraine due to significant safety concerns and lack of documented efficacy but remain frequently used in the emergency department setting, which significantly increases healthcare costs

Reference

  1. 1.
    Martelletti P et al (2018) Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trial. J Headache Pain 19:101.  https://doi.org/10.1186/s10194-018-0929-0 CrossRefPubMedGoogle Scholar

Copyright information

© The Author(s). 2018

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors and Affiliations

  • Paolo Martelletti
    • 1
  • Piero Barbanti
    • 2
  • Licia Grazzi
    • 3
  • Giulia Pierangeli
    • 4
  • Innocenzo Rainero
    • 5
  • Pierangelo Geppetti
    • 6
  • Anna Ambrosini
    • 7
  • Paola Sarchielli
    • 8
  • Cristina Tassorelli
    • 9
    • 10
  • Eric Liebler
    • 11
  • Marina de Tommaso
    • 12
  • on Behalf of the PRESTO Study Group
  1. 1.Department of Clinical and Molecular MedicineSapienza UniversityRomeItaly
  2. 2.Headache and Pain UnitIstituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele PisanaRomeItaly
  3. 3.Neuroalgology UnitCarlo Besta Neurological Institute and FoundationMilanItaly
  4. 4.IRCCS Istituto delle Scienze Neurologiche di BolognaBolognaItaly
  5. 5.Department of NeuroscienceUniversity of TurinTurinItaly
  6. 6.Headache CentreUniversity Hospital of CareggiFlorenceItaly
  7. 7.IRCCS NeuromedPozzilliItaly
  8. 8.Neurologic ClinicSanta Maria della Misericordia HospitalPerugiaItaly
  9. 9.Headache Science CentreIRCCS C. Mondino FoundationPaviaItaly
  10. 10.Department of Brain and Behavioral SciencesUniversity of PaviaPaviaItaly
  11. 11.electroCore, Inc.Basking RidgeUSA
  12. 12.Neurophysiology and Pain UnitUniversity of Bari Aldo MoroBariItaly

Personalised recommendations